Cargando…
COVID cardiomyopathy: Is it time to involve the cardiologists?
Autores principales: | Chowdhury, Mohammed, Maharaj, Valmiki R., Francis, Gary S., Alexy, Tamas, Fraser, Meg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881815/ https://www.ncbi.nlm.nih.gov/pubmed/33107477 http://dx.doi.org/10.4103/ijmr.IJMR_3760_20 |
Ejemplares similares
-
Update on COVID-19 Myocarditis
por: Agdamag, Arianne Clare C., et al.
Publicado: (2020) -
COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond
por: Fraser, Meg, et al.
Publicado: (2022) -
Cardiac Transplantation and the Use of Cannabis
por: Shah, Hirak, et al.
Publicado: (2021) -
Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019) -
Cardiologists and diabetes
por: Öngen, Zeki
Publicado: (2016)